Alkermes – A global biopharmaceutical company

About Us

About Alkermes

Our Company Message From the CEO Locations

Leadership

Management Team Board of Directors

Collaborations

Strategic Partners

Products

Products Overview

United States

ARISTADA^® VIVITROL^® U.S. Products Using Alkermes Technologies

European Union

EU Products Using Alkermes Technologies

Research & Development

R&D Overview Our R&D Approach Pipeline Technology Platforms Manufacturing

Other Information

Clinical Trials Expanded Access

Responsibility

Alkermes Corporate Giving Investigator Initiated Trials Educational Grants Patient Engagement Support ALKERMES Inspiration Grants™

Investors

Corporate Overview Press Releases Investor Events Stock Information SEC Filings Annual Reports

Financials

Snapshot Trading Statistics

Other Information

Email Alerts

News & Events

Press Releases Media Kit

Careers

Working At Alkermes Meet Alkermes Employees Search Jobs Benefits Employee FAQs

Latest News

Alkermes Announces Webcast of Analyst and Investor Event on September 26, 2016 Read More
Alkermes Launches Competitive Grants Program to Support People Affected by Mental Health and Substance Use Disorders Read More
Alkermes’ Corporate Presentation to be Webcast at the Morgan Stanley Global Healthcare Conference Read More